Andrzej Bożek, Aleksandra Spyra, Natalia Tekiela, Maksymilian Dobosz, Aleksandra Mitka, Martyna Miodońska
{"title":"60-74岁轻度认知障碍患者的合并症和长期用药分析","authors":"Andrzej Bożek, Aleksandra Spyra, Natalia Tekiela, Maksymilian Dobosz, Aleksandra Mitka, Martyna Miodońska","doi":"10.1177/13872877251376674","DOIUrl":null,"url":null,"abstract":"<p><p>Mild cognitive impairment (MCI) is a condition that may precede the onset of Alzheimer's disease. Of interest are factors that influence the induction of MCI. In this study, we assessed 92 patients with MCI (aged 60-74 years) and 118 controls for comorbidities and medication. In the MCI group, multimorbidity was observed significantly more often. MCI correlated with age, overweight, multimorbidity, the presence of allergic disease, depression, use of sleep medications and tramadol derivatives. The results indicate a higher possibility of MCI in the 60-year-old group, especially in those with multimorbidity and using certain types of drugs.</p>","PeriodicalId":14929,"journal":{"name":"Journal of Alzheimer's Disease","volume":" ","pages":"13872877251376674"},"PeriodicalIF":3.1000,"publicationDate":"2025-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Analysis of comorbidities and chronically used medications in patients with mild cognitive impairment aged 60-74 years.\",\"authors\":\"Andrzej Bożek, Aleksandra Spyra, Natalia Tekiela, Maksymilian Dobosz, Aleksandra Mitka, Martyna Miodońska\",\"doi\":\"10.1177/13872877251376674\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Mild cognitive impairment (MCI) is a condition that may precede the onset of Alzheimer's disease. Of interest are factors that influence the induction of MCI. In this study, we assessed 92 patients with MCI (aged 60-74 years) and 118 controls for comorbidities and medication. In the MCI group, multimorbidity was observed significantly more often. MCI correlated with age, overweight, multimorbidity, the presence of allergic disease, depression, use of sleep medications and tramadol derivatives. The results indicate a higher possibility of MCI in the 60-year-old group, especially in those with multimorbidity and using certain types of drugs.</p>\",\"PeriodicalId\":14929,\"journal\":{\"name\":\"Journal of Alzheimer's Disease\",\"volume\":\" \",\"pages\":\"13872877251376674\"},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2025-09-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Alzheimer's Disease\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1177/13872877251376674\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"NEUROSCIENCES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Alzheimer's Disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/13872877251376674","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
Analysis of comorbidities and chronically used medications in patients with mild cognitive impairment aged 60-74 years.
Mild cognitive impairment (MCI) is a condition that may precede the onset of Alzheimer's disease. Of interest are factors that influence the induction of MCI. In this study, we assessed 92 patients with MCI (aged 60-74 years) and 118 controls for comorbidities and medication. In the MCI group, multimorbidity was observed significantly more often. MCI correlated with age, overweight, multimorbidity, the presence of allergic disease, depression, use of sleep medications and tramadol derivatives. The results indicate a higher possibility of MCI in the 60-year-old group, especially in those with multimorbidity and using certain types of drugs.
期刊介绍:
The Journal of Alzheimer''s Disease (JAD) is an international multidisciplinary journal to facilitate progress in understanding the etiology, pathogenesis, epidemiology, genetics, behavior, treatment and psychology of Alzheimer''s disease. The journal publishes research reports, reviews, short communications, hypotheses, ethics reviews, book reviews, and letters-to-the-editor. The journal is dedicated to providing an open forum for original research that will expedite our fundamental understanding of Alzheimer''s disease.